
Pfenex Reports Second Quarter 2020 Results and Provides Business Update
Commercialization and launch of first royalty bearing products position company for next phase of growth Multiple U.S. health plans add Teriparatide Injection to their formulary upon its June 2020 launch as Pfenex and Alvogen continue to pursue therapeutic …